Chronic exposure to cadmium (Cd) via food and drinking water is a major hum
an health concern. We have previously shown that metallothionein (MT), a me
tal-binding protein, plays an important role in protecting against Cd toxic
ity produced by repeated sc injections. However, it is unclear whether MT p
rotects against Cd-induced nephrotoxicity following chronic oral exposure,
a route with obvious human relevance. To clarify this issue, MT-I/II knocko
ut (MT-null) and background-matched wild-type (WT) mice were allowed free a
ccess to drinking water containing CdCl2 (30, 100, and 300 ppm Cd), or feed
containing CdCl2 (100 ppm Cd) for 6 months, and the resultant nephrotoxici
ty was examined. Chronic oral Cd exposure produced a dose-dependent accumul
ation of Cd in liver and kidney of WT mice, reaching levels up to 50 mug Cd
/g tissue. Immunohistological localization of renal MT indicated that chron
ic oral Cd exposure in WT mice greatly increased MT in the proximal tubules
and the medulla, with cellular localization in both the cytoplasm and nucl
ei. As expected, no MT was detected in kidneys of MT-null mice. After 6 mon
ths of Cd exposure, tissue Cd concentrations in MT-null mice were only abou
t one-fifth of that in WT mice. Even though the renal Cd concentrations wer
e much lower in the MT-null mice, they were more sensitive than WT mice to
Cd-induced renal injury, as evidenced by more severe nephropathic lesions,
increased urinary excretion of gamma -glutamyl-transferase and glucose, and
elevated blood urea nitrogen. Six months of Cd exposure to MT-null animals
resulted in greater increases in renal caspase-3 activity, an indicator of
apoptosis, than to WT mice. In conclusion, this study demonstrates that la
ck of MT renders MT-null mice vulnerable to Cd-induced nephrotoxicity after
chronic oral exposure, the primary route of human Cd exposure.